Search Results

Genetic characteristic of mumps virus from 2012 to 2016 and its serum antibody level among general healthy population during 2018–2020 in Jiangsu Province, China.

• Authors : Deng, Xiuying; Hu, Ying; Lu, Peishan

Subjects: MUMPS; COMMUNICABLE diseases; VIRUS diversityJIANGSU Sheng (China); CHINA

• Source: BMC Infectious Diseases; 7/22/2024, Vol. 24 Issue 1, p1-8, 8p

Record details

The Elecsys® Anti-SARS-CoV-2 and Elecsys® Anti-SARS-CoV-2 S antibody assays: Differentiating between vaccination and infection, and assessing long-term performance.

• Authors : Quee, Franke A.; Hogema, Boris M.; Molier, Michel

Subjects: VACCINATION status; IMMUNOGLOBULINS; DIAGNOSTIC use of polymerase chain reaction

• Source: PLoS ONE; 7/18/2024, Vol. 19 Issue 7, p1-11, 11p

Record details

Agricola

Record details

Szczepionka przeciwko COVID-19 czy przeciwko zakażeniu SARS-CoV-2?

• Authors : Rieske, Piotr

Subjects: IMMUNIZATION; PATIENT safety; HERD immunity

• Source: Polish Journal of Allergology / Alergologia Polska; 2024, Vol. 11 Issue 2, p131-145, 15p

Record details

Herd immunity no-show.

• Authors : Taylor, Luke

Subjects: *HERD immunity; *COVID-19; *VIRUS disease transmissionMANAUS (Brazil)

• Source: New Scientist. 1/30/2021, Vol. 249 Issue 3319, p10-10. 1p.

Record details

Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial.

• Authors : Prins, Manon L. M.; Roozen, Geert V. T.; Pothast, Cilia. R.

Subjects: COVID-19 vaccines; IMMUNE response; VACCINATIONNETHERLANDS

• Source: NPJ Vaccines; 1/2/2024, Vol. 9 Issue 1, p1-10, 10p

Record details

Serological surveillance of GI norovirus reveals persistence of blockade antibody in a Jidong community-based prospective cohort, 2014-2018.

• Authors : Jing-Rong Yu; Dong-Jie Xie; Jia-Heng Li

Subjects: BLOOD groups; NOROVIRUSES; IMMUNOGLOBULINS

• Source: Frontiers in Cellular & Infection Microbiology; 2023, p1-15, 15p

Record details

Assessment of hybrid population immunity to SARS-CoV-2 following breakthrough infections of distinct SARS-CoV-2 variants by the detection of antibodies to nucleoprotein.

• Authors : den Hartog, Gerco; Andeweg, Stijn P.; Hoeve, Christina E.

Subjects: HERD immunity; BREAKTHROUGH infections; SARS-CoV-2

• Source: Scientific Reports; 10/26/2023, Vol. 13 Issue 1, p1-10, 10p

Record details

Antibody escape, the risk of serotype formation, and rapid immune waning: Modeling the implications of SARS-CoV-2 immune evasion.

• Authors : Albright, Catherine; Van Egeren, Debra; Thakur, Aditya

Subjects: SARS-CoV-2; IMMUNOGLOBULINS; HERD immunity

• Source: PLoS ONE; 10/18/2023, Vol. 18 Issue 10, p1-17, 17p

Record details

SARS‐CoV‐2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022.

• Authors : Kagucia, E. Wangeci; Ziraba, Abdhala K.; Nyagwange, James

Subjects: HERD immunity; SEROPREVALENCE; CITY dwellersKENYA; NAIROBI (Kenya)

• Source: Influenza & Other Respiratory Viruses; Sep2023, Vol. 17 Issue 9, p1-11, 11p

Record details